The largest database of trusted experimental protocols

45 protocols using mk 2206

1

Chemotaxis Assay for Macrophage Migration

Check if the same lab product or an alternative is used in the 5 most similar protocols
Migration assays were performed as previously described54 . Freshly isolated BMDMs (100,000 cells) were seeded in the top chamber of a 24-well PET membrane (8 mm pore size). Cells translocated to the lower chamber in response to exposure in the lower chamber of vehicle or 100 ng/ml CX3CL1 (472-FF; R&D) in the presence or absence of either an AKT inhibitor (MK-2206; 10 μM, Cayman), PI3K inhibitor (BEZ235; 10 μM, Cayman), EGFR inhibitor (erlotinib, 10 μM, LC laboratories) or NF-κB inhibitor (JSH23, 30 μM, Sigma-Aldrich) for 3 h. Cells in the upper chamber were removed with a cotton swab, and the filters were fixed with 70% ethanol and stained with 2% crystal violet. Filters were photographed on a Leica DMi1 microscope and total cell number was counted.
+ Open protocol
+ Expand
2

Polarization of Bone Marrow-Derived Macrophages

Check if the same lab product or an alternative is used in the 5 most similar protocols
BMMФ were stimulated either with IL-4 (10 ng/ml, AF-214-14, Peprotech), lipopolysaccharide (100 ng/ml, Sigma) or dexamethasone (100nM, D4902, Sigma) to respectively achieve M(IL-4), M(LPS) or M(GC) polarization state. In some experiments, BMMФ were treated with C75 (Sigma), Cerulenin (Sigma), Etomoxir (Sigma), pan-AKT inhibitor MK-2206 (1 mM, Cayman Chemical), 25-hydroxycholesterol (10 μM, Cayman chemical), N-acetyl cysteine (10mM, Sigma), Diphenyleneiodonium chloride (DPI, 5 μM, Sigma), L-NG-Nitroarginine methyl ester (L-NAME, 1mM, Cayman Chemical), Allopurinol (100 μM, Sigma), hydrogen peroxide (Sigma), SIRT1 activator II (Sigma), EX-527 (Sigma), Compound C (Sigma), AICAR (Abcam), HMGCoA (Sigma), water-soluble cholesterol (Cholesterol–methyl-β-cyclodextrin, Sigma) or Simvastatin (Sigma).
For fatty acid treatment, palmitic or oleic acid (Cayman) were solubilized at 100mM in absolute ethanol at 60°C. Fatty acid were conjugated at the desired concentration using a sonicator water bath into the macrophage culture medium to avoid endotoxin contamination from BSA54 (link).
+ Open protocol
+ Expand
3

Resolvin-Mediated Inhibition of Inflammatory Signaling

Check if the same lab product or an alternative is used in the 5 most similar protocols
Recombinant human or mouse IL-17A was purchased from R&D Systems. The D series resolvins, RvD1 and RvD2, and MK2206 (Akt inhibitor) were from Cayman Chemical. SB202190 (p38 MAP kinase inhibitor), SB216763 (GSK-3β inhibitor), SN50 (NF-κB inhibitor), SP600125 (JNK inhibitor) were obtained from EMD-Millipore. LY294002 (PI3K inhibitor) and LY30351 (inactive analog of LY294002) were purchased from Sigma-Aldrich. Rabbit polyclonal antibody to Del-1 was from ProteinTech. Rabbit monoclonal antibody (mAb) to β-actin (13E5), rabbit IgG antibodies to total Akt (phosphorylation state–independent), phospho-Akt (Ser473), total GSK-3β and phospho-GSK-3β (Ser9), as well as rabbit anti-phospho-C/EBPβ (Thr-188) and anti-phospho-threonine IgG antibodies were purchased from Cell Signaling Technology. Rabbit IgG antibodies to GPR32 and to ALX/FPR2 were from Abcam and Abnova, respectively. FITC- or PE-conjugated goat anti-rabbit IgG and rabbit IgG antibody to C/EBPβ were purchased from Santa Cruz Biotechnology. All reagents (including those mentioned in the description of assays below) were used at doses based on our previously published work or on experiments in this study (see Supplementary fig. 1 and 4).
+ Open protocol
+ Expand
4

AKT Inhibitor MK-2206 Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
The AKT inhibitor MK-2206 (8-[4-(1-Aminocyclobutyl)phenyl)-9-phenyl-[1,2,4]triazolo[3,4-f][1,6]naphthyridin-3(2H)-one hydrochloride [1:1] was obtained from Cayman chemical (CAS 1032350-13-2). For experiments, cells were seeded at a density of 1.5 × 105 in 6 cm dishes. The next day, MK2206 (diluted from a stock solution formulated in DMSO) was added to cultures at a concentration of 0.1 µM. After 24-hour exposure, the cells were collected and lysis for immunoblotting assays.
+ Open protocol
+ Expand
5

Characterization of Cell Signaling Pathways

Check if the same lab product or an alternative is used in the 5 most similar protocols
Culture media and supplements were purchased from Wisent (St-Jean-Baptiste, Quebec, Canada) and Gibco (Grand Island, NY, USA); AG1478, Gö6976, and MK-2206 were obtained from Cayman Chemical (Ann Arbor, MI, USA); LY294002 was purchased from Chemdea (Ridgewood, NJ, USA); rapamycin was obtained from LC Laboratories (Woburn, MA, USA); and rhEGF was a gift from Dr. Stéphane Lefrançois (INRS—Centre AFSB, Laval, QC, Canada).
+ Open protocol
+ Expand
6

Ubiquitination Pathway Regulation in Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
The primers were synthesized and PAGE purified by IDT DNA. Fugene 6 transfection reagent was purchased from Promega while Lipofectamine RNAiMax was from Life Technologies/Invitrogen. All cell culture reagents including media, antibiotics were from GIBCO/Invitrogen. Antibodies to total Ubiquitin (clone P4D1) was from Santacruz Biotechnology, Luciferase (Millipore), pAKT, AKT (Cell Signaling), Ubiquitin, Lys63 specific (clone Apu3, Millipore), His-tag (clone H3 and C-term, Invitrogen) or Millipore (H8 clone). FLAG tag-HRP antibody (Clone M2) was purchased from Sigma Aldrich. HRP-conjugated and fluorophore-conjugated secondary antibodies were from Jackson ImmunoResearch. ON-TARGET plus siRNA to TRAF6 and scrambled control siRNA were obtained from GE Life Sciences/Dharmacon. D-Luciferin was from Xenogen Corp while GloSensor was from Promega. Erlotinib was a kind gift from Genentech. Tyrphostin AG1478 was obtained from Cayman Chemical. TNF-α antagonist (WP9QY) and IL-1R antagonist were from SantaCruz biotechnology. Recombinant IGF-1, IL-1α were from PepreoTech. CI-1040, GF109203X, NVP-AEW541 and MK2206 (Cayman Chemical), and Linsitinib (LC Laboratories). Protein A and Protein G sepharose beads were from GE HealthCare. Purified NEDD4-1 (Sigma Aldrich), Myc-tagged ubiquitin (Cat. No. U-115) UBE1 (Cat. No. E305), and UBCH5 (Cat. No. E2-616) all were from Boston Biochemicals.
+ Open protocol
+ Expand
7

Phosphorylation of SR Proteins Regulates Cell Signaling

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cell Signaling Technology custom developed the pSRPK2(S494), pSRPK2(S497), and pSRPK2(S494/S497) antibodies for this study. Antibodies were obtained from following sources: SRPK1 and SRPK2 from BD Biosciences; ACLY, FASN, SCD1, S6, pS6(S235/S236), pS6(S240/S244), S6K1, pS6K1(T389), TSC2, and V5 from Cell Signaling Technology; ACSS2 and GAPDH from Sigma-Aldrich; FDFT1 from Abcam; SRSF1, ACTIN, GST, LAMIN A/C, and SREBP1 from Santa Cruz; HA from Covance; U1-70k from Synaptic Systems. Monoclonal antibody for the phosphorylated SR proteins was generated from the mAb104 hybridoma cell line (ATCC) (Figures 3B and 3H) or purchased from invitrogen (mAB1H4) (Figure 5G). Reagents were obtained from following sources: Insulin, rapamycin, PF4708671, and actinomycin D from Sigma-Aldrich; Torin1 from Tocris Bioscience; rapamycin from Calbiochem; MK2206 from Cayman Chemical; SRPIN340 from Selleck Chemicals and Milstein Chemistry Core Facility (Weill Cornell Medicine).
+ Open protocol
+ Expand
8

Macrophage Response to oxLDL and Cholesterol

Check if the same lab product or an alternative is used in the 5 most similar protocols
BMDMφs and PMφs were cultured for 24 h with human medium oxLDL (100 μg/ml, Kalen Biomedical, no. 770202) or cholesterol (50 μg/ml, Sigma-Aldrich, no. C3045), followed by ultrapure LPS stimulation (10 ng/ml, InvivoGen, no. tlrl-3pelps) for up to 6 h, or CpG (300 nM) (InvivoGen, no. tlrl-1826), Pam3CSK4 (10 ng/ml) (Tocris Bioscience, no. 4633), or bpV (HOpic) (10 µM) (Sigma-Aldrich, no. SML0884) stimulation for up to 3 h. Ethanol (0.5%) was used as a carrier control for cholesterol. For inhibitor experiments, MK-2206 (3 µM) (Cayman Chemical, no. 11593), AKT2i (3 µM) (Sigma-Aldrich, no. 124029), Mito-TEMPO hydrate (25 µM) (Cayman Chemical, no. 16621), and bpV (HOpic) (10 µM) were added 1 h prior to LPS stimulation. For assessing the accumulation of oxLDL, a mixture of DiI-oxLDL and oxLDL (10 and 90 μg/ml, respectively) were added to PMφs for 24 h. In all experiments, Mφs were first cultured for 24 h with or without oxLDL or cholesterol. The groups without oxLDL or cholesterol served as controls. The control group for cholesterol loading was cultured with media containing the same concentration of ethanol as the cholesterol group. Cells were then stimulated with LPS from 0 up to 3 h. At each time point, the groups with versus without oxLDL or cholesterol were compared and changes over time were determined.
+ Open protocol
+ Expand
9

Biochemical Inhibitors for Cell Signaling

Check if the same lab product or an alternative is used in the 5 most similar protocols
Okadaic Acid (10011490), TMP269 (17738), MC 1568 (16265), BML-210 (10005019), MK-2206(11593) were purchased from Cayman. DT-061 (S8774) was purchased from SELLECK CHEMICALS. 14-3-3 Antagonist I, 2–5 (100081) was purchased from Sigma.
+ Open protocol
+ Expand
10

MK-2206 Impacts PC3 Cell Proliferation

Check if the same lab product or an alternative is used in the 5 most similar protocols
PC3 parental, CKB shRNA or knockout cells were treated with DMSO (#276855, Sigma) or 25uM MK-2206 (#11593, Cayman Chemical) for 48h before collecting cell lysate. For cell proliferation assay, 600 cells were seeded into 96-well plate in RPMI 1640 culture medium containing 10% FBS. In the next day, medium was changed to RPMI 1640 supplemented with 1.25% FBS. Fluorescence was detected every 24 h using Alamar Blue reagent, incubating at 37°C for 4 h, then reading on a fluorescence plate reader (#Infinite M1000, Tecan) with excitation at 530nm and emission at 595nm.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!